EMEA-002854-PIP01-20
Key facts
| Active substance |
(1R,2R,3S,4S,5R,6S)-cyclohexane-1,2,3,4,5,6-hexayl-hexakis (dihydrogen phosphate)
|
| Therapeutic area |
Other
|
| Decision number |
P/0472/2020
|
| PIP number |
EMEA-002854-PIP01-20
|
| Pharmaceutical form(s) |
Solution for infusion
|
| Condition(s) / indication(s) |
Treatment of calciphylaxis
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Sanifit Therapeutics S.A.
Email: info@sanifit.com |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|